NOT-AI-24-086: Notice of Early Expiration of "Notice of Special Interest (NOSI): Accelerating Malaria Vaccine Discovery", NOT-AI-22-014

Notice of Early Expiration of "Notice of Special Interest (NOSI): Accelerating Malaria Vaccine Discovery", NOT-AI-22-014

Notice Number:

NOT-AI-24-086

Key Dates

Release Date:

November 20, 2024

Related Announcements

December 2, 2021 - Notice of Special Interest (NOSI): Accelerating Malaria Vaccine Discovery. See NOSI NOT-AI-22-014.

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to inform the extramural community that NOT-AI-22-014, “Notice of Special Interest (NOSI): Accelerating Malaria Vaccine Discovery,” will be expired as of November 20, 2024.

Potential applicants interested in this announcement are encouraged to consider NOT-AI-24-072, “Notice of Special Interest (NOSI): Accelerating Malaria Vaccine and Monoclonal Antibody Discovery”.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Annie Mo, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3320
Email: [email protected]

Financial/Grants Management Contact(s)

Vandhana Khurana
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-669-2966
Email: [email protected]